Literature DB >> 24820146

Wnt signaling in ankylosing spondylitis.

Maripat Corr1.   

Abstract

The mechanisms that lead to bony fusion in ankylosing spondylitis (AS) are yet to be fully defined. In recent years, there have been several advances in our understanding of this complex disease. Here, the potential impact of the Wnt signaling pathway will be discussed. This pathway is involved in bone morphogenesis and homeostasis. Perturbations in the normal regulation have been implicated in abnormal bone formation (e.g., osteophytes). Levels of Wnt regulatory proteins like Dickkopf have been investigated as potential biomarkers of disease. This pathway might be involved in other aspects of this disease including T cell activation and differentiation, and in bone marrow adipogenesis. The pathways leading to the unique pathology and bony fusion in AS are complex and the Wnt pathway might play a critical contributing role.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24820146     DOI: 10.1007/s10067-014-2663-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  21 in total

1.  Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytes.

Authors:  Sujatha Muralidharan; Patrick J Hanley; Enli Liu; Rikhia Chakraborty; Catherine Bollard; Elizabeth Shpall; Cliona Rooney; Barbara Savoldo; John Rodgers; Gianpietro Dotti
Journal:  J Immunol       Date:  2011-10-19       Impact factor: 5.422

2.  LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

Authors:  Y Gong; R B Slee; N Fukai; G Rawadi; S Roman-Roman; A M Reginato; H Wang; T Cundy; F H Glorieux; D Lev; M Zacharin; K Oexle; J Marcelino; W Suwairi; S Heeger; G Sabatakos; S Apte; W N Adkins; J Allgrove; M Arslan-Kirchner; J A Batch; P Beighton; G C Black; R G Boles; L M Boon; C Borrone; H G Brunner; G F Carle; B Dallapiccola; A De Paepe; B Floege; M L Halfhide; B Hall; R C Hennekam; T Hirose; A Jans; H Jüppner; C A Kim; K Keppler-Noreuil; A Kohlschuetter; D LaCombe; M Lambert; E Lemyre; T Letteboer; L Peltonen; R S Ramesar; M Romanengo; H Somer; E Steichen-Gersdorf; B Steinmann; B Sullivan; A Superti-Furga; W Swoboda; M J van den Boogaard; W Van Hul; M Vikkula; M Votruba; B Zabel; T Garcia; R Baron; B R Olsen; M L Warman
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

3.  Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine.

Authors:  Santhakumar Manicassamy; Boris Reizis; Rajesh Ravindran; Helder Nakaya; Rosa Maria Salazar-Gonzalez; Yi-Chong Wang; Bali Pulendran
Journal:  Science       Date:  2010-08-13       Impact factor: 47.728

Review 4.  To Wnt or not to Wnt: the bone and joint health dilemma.

Authors:  Rik J Lories; Maripat Corr; Nancy E Lane
Journal:  Nat Rev Rheumatol       Date:  2013-03-05       Impact factor: 20.543

5.  Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis.

Authors:  Heiner Appel; Gisela Ruiz-Heiland; Joachim Listing; Jochen Zwerina; Martin Herrmann; Ruediger Mueller; Hildrun Haibel; Xenofon Baraliakos; Axel Hempfing; Martin Rudwaleit; Joachim Sieper; Georg Schett
Journal:  Arthritis Rheum       Date:  2009-11

6.  Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells.

Authors:  Yi Ding; Shiqian Shen; Andreia C Lino; Maria A Curotto de Lafaille; Juan J Lafaille
Journal:  Nat Med       Date:  2008-02-03       Impact factor: 53.440

7.  Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis.

Authors:  Dimitrios Daoussis; Stamatis-Nick C Liossis; Elena E Solomou; Anastasia Tsanaktsi; Konstadina Bounia; Maria Karampetsou; Georgios Yiannopoulos; Andrew P Andonopoulos
Journal:  Arthritis Rheum       Date:  2010-01

8.  IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells.

Authors:  Jonathan P Sherlock; Barbara Joyce-Shaikh; Scott P Turner; Cheng-Chi Chao; Manjiri Sathe; Jeff Grein; Daniel M Gorman; Edward P Bowman; Terrill K McClanahan; Jennifer H Yearley; Gérard Eberl; Christopher D Buckley; Robert A Kastelein; Robert H Pierce; Drake M Laface; Daniel J Cua
Journal:  Nat Med       Date:  2012-07-01       Impact factor: 53.440

9.  Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis.

Authors:  Ali Taylan; Ismail Sari; Baris Akinci; Safak Bilge; Didem Kozaci; Servet Akar; Ayfer Colak; Hulya Yalcin; Necati Gunay; Nurullah Akkoc
Journal:  BMC Musculoskelet Disord       Date:  2012-10-02       Impact factor: 2.362

10.  Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?

Authors:  Carla G S Saad; Ana C M Ribeiro; Julio C B Moraes; Liliam Takayama; Celio R Goncalves; Marcelo B Rodrigues; Ricardo M de Oliveira; Clovis A Silva; Eloisa Bonfa; Rosa M R Pereira
Journal:  Arthritis Res Ther       Date:  2012-10-12       Impact factor: 5.156

View more
  14 in total

Review 1.  Update on ankylosing spondylitis: current concepts in pathogenesis.

Authors:  Judith A Smith
Journal:  Curr Allergy Asthma Rep       Date:  2015-01       Impact factor: 4.806

2.  HDAC1 regulates inflammation and osteogenic differentiation of ankylosing spondylitis fibroblasts through the Wnt-Smad signaling pathway.

Authors:  Yong Zeng; Rui He; Yong Liu; Ting Luo; Qing Li; Yu He; Miao Fang; Taiping Wang
Journal:  J Orthop Surg Res       Date:  2022-07-06       Impact factor: 2.677

Review 3.  Inflammatory bowel disease: an overview of Chinese herbal medicine formula-based treatment.

Authors:  Shuo Yuan; Qi Wang; Jiao Li; Jia-Chen Xue; You Li; Huan Meng; Xiao-Ting Hou; Ji-Xing Nan; Qing-Gao Zhang
Journal:  Chin Med       Date:  2022-06-18       Impact factor: 4.546

4.  IL-36γ inhibits differentiation and induces inflammation of keratinocyte via Wnt signaling pathway in psoriasis.

Authors:  Wenming Wang; Xiaoling Yu; Chao Wu; Hongzhong Jin
Journal:  Int J Med Sci       Date:  2017-08-18       Impact factor: 3.738

5.  Discriminating Value of Calprotectin in Disease Activity and Progression of Nonradiographic Axial Spondyloarthritis and Ankylosing Spondylitis.

Authors:  Jinxian Huang; Zhihua Yin; Guoxiang Song; Shengjin Cui; Jinzhao Jiang; Lijun Zhang
Journal:  Dis Markers       Date:  2017-05-24       Impact factor: 3.434

6.  Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study.

Authors:  Fabio Massimo Perrotta; Fulvia Ceccarelli; Cristiana Barbati; Tania Colasanti; Antonia De Socio; Silvia Scriffignano; Cristiano Alessandri; Ennio Lubrano
Journal:  J Immunol Res       Date:  2018-05-02       Impact factor: 4.818

7.  Identification of differential modules in ankylosing spondylitis using systemic module inference and the attract method.

Authors:  Fang-Chang Yuan; Bo Li; Li-Jun Zhang
Journal:  Exp Ther Med       Date:  2018-05-07       Impact factor: 2.447

8.  Alteration of Bone Turnover Markers in Canonical Wingless Pathway in Patients With Ankylosing Spondylitis.

Authors:  Jinxian Huang; Guoxiang Song; Zhihua Yin; Zhongchao Fu; Zhizhong Ye
Journal:  Arch Rheumatol       Date:  2016-04-15       Impact factor: 1.472

9.  Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Ankylosing Spondylitis.

Authors:  Inês P Perpétuo; Rita Raposeiro; Joana Caetano-Lopes; Elsa Vieira-Sousa; Raquel Campanilho-Marques; Cristina Ponte; Helena Canhão; Mari Ainola; João E Fonseca
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

Review 10.  Emerging Role and Therapeutic Implication of Wnt Signaling Pathways in Autoimmune Diseases.

Authors:  Juan Shi; Shuhong Chi; Jing Xue; Jiali Yang; Feng Li; Xiaoming Liu
Journal:  J Immunol Res       Date:  2016-03-27       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.